Buscar
-
Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
(Nature Genetics. vol. 50, n° 12, pp. 1755, 2018-12)Article de revue -
Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study
(Journal of the American Heart Association. vol. 8, n° 15, pp. e012994, 2019-08-06)Article de revueLibre acceso -
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation
(Scientific Reports. vol. 9, n° 1, pp. 3750, 2019-03-06)Article de revueLibre acceso -
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
(BMC Cancer. vol. 18, n° 1, pp. 194, 2018-02-17)Article de revueLibre acceso -
Management of severe asthma exacerbation: guidelines from the Societe Francaise de Medecine d'Urgence, the Societe de Reanimation de Langue Francaise and the French Group for Pediatric Intensive Care and Emergencies
(Annals of intensive care. vol. 9, n° 1, pp. 115, 2019-10-10)Article de revueLibre acceso -
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function
(Nature Communications. vol. 9, n° 1, pp. 2098, 2018-05-29)Article de revueLibre acceso -
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia
(Ophthalmology. vol. 126, n° 3, pp. 393-406, 2019-03)Article de revueLibre acceso -
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma
(JAMA network open. vol. 2, n° 4, pp. e192093, 2019-04-05)Article de revueLibre acceso -
Impaired Systolic and Diastolic Left Ventricular Function in Children with Chronic Kidney Disease - Results from the 4C Study
(Scientific Reports. vol. 9, n° 1, pp. 11462, 2019-08-07)Article de revueLibre acceso -
First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2)
(Clinical Infectious Diseases. vol. 67, n° 8, pp. 1161-1167, 2018-09-28)Article de revueLibre acceso